Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22%2ANeoplasms%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22%2ANeoplasms%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22%2ANeoplasms%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (41.518)
1
A study to compare treatment after surgery of abemaciclib combined with standard endocrine therapy versus endocrine therapy alone in patients with early stage breast cancer : A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High-Risk, Node-Positive, Early-Stage, Hormone Receptor-Positive, Human Epidermal Receptor 2-Negative, Breast Cancer - MonarchE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Study with investigational drug PF-06463922 and comparator crizotinib in patients with a specific type of advanced lung cancer : A Phase 3, randomized, open label study of lorlatinib (PF 06463922) monotherapy versus crizotinib monotherapy in the first line treatment of patients with advanced ALK positive non small cell lung cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC) : An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A trial of oral azacitidine compared to standard treatment in patients with relapsed lymphoma. : Randomized Phase 3 Study evaluating the Efficacy and the Safety of Oral Azacitidine (CC-486) compared to Investigator’s Choice Therapy in Patient with Relapsed or Refractory Angioimmunoblastic T cell Lymphoma - ORACLE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A phase 3 trial studying how well E7080 works in treating patients with advanced thyroid cancer who no longer gain benefit from radioactive iodine therapy. The trial is taking place worldwide, patients and their physician do not know if they are receiving the active drug or a dummy drug. : A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Phase 3 Trial of Lenvatinib E7080 in 131I-Refractory Differentiated Thyroid Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A multicenter clinical study with Nivolumab for subjects with confirmed stage III or stage IV melanoma after treament with an Anti-CTLA-4 antibody. : A Single-Arm, Open-Label, Multicenter Clinical Trial with Nivolumab (BMS-936558) for Subjects with Histologically Confirmed Stage III (unresectable) or Stage IV Melanoma Progressing After Prior Treatment Containing an Anti-CTLA-4 Monoclonal Antibody
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A review of the LightPath Imaging System using the tracer 68Ga-RM2 in helping to show the boundaries of the breast cancer during removal of the tumour. : Evaluation of the LightPath Imaging System and the PET tracer 68Ga-RM2 in wide local excision (WLE) for breast cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Study of Atezolizumab Versus Placebo Given with Paclitaxel, Carboplatin, and Bevacizumab to Patients with Newly-Diagnosed Stage III/IV Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer : A PHASE III, MULTICENTER, RANDOMIZED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO ADMINISTERED INCOMBINATION WITH PACLITAXEL, CARBOPLATIN, AND BEVACIZUMAB FOR PATIENTS WITH NEWLY-DIAGNOSEDSTAGE III OR STAGE IV OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A randomized, open-label, multicenter study comparing the efficacy, safety and tolerability of rovalpituzumab tesirine versus topotecan for DLL3high SCLC subjects with first relapse/recurrence following front-line platinum-based chemotherapy. : A Randomized, Open-Label, Multicenter, Phase 3 Study of Rovalpituzumab Tesirine Compared with Topotecan for Subjects with Advanced or Metastatic DLL3high Small Cell Lung Cancer (SCLC) who have First Disease Progression During or Following Front-Line Platinum-Based Chemotherapy (TAHOE) - TAHOE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Phase 1/2 Study on the effects of the LOXO-292 (study drug) in Pediatric Patients with Advanced Solid or Primary Central Nervous System Tumors : A Phase 1/2 Study of the Oral RET Inhibitor LOXO-292 in Pediatric Patients with Advanced RET-Altered Solid or Primary Central Nervous System Tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[4152]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
41.518
Aufsätze
41.518
E-Artikel
41.518
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
41.518
610
36.698
Study Type: Interventional
18.140
Recruitment Status: Not yet recruiting
11.770
Phase: Phase 3
11.212
Recruitment Status: Authorised-recruitment may ...
9.640
Phase: Phase 2
5.158
Recruitment Status: Recruiting
4.576
Study Type: Observational
4.044
Recruitment Status: Completed
2.444
Phase: Phase 1
2.336
Medical Condition: ;Neoplasms
1.420
Recruitment Status: Complete: follow-up complete
1.004
Phase: Phase 4
472
Recruitment Status: Complete: follow-up continuing
460
Medical Condition: Health Condition 1: C509- Ma...
408
Phase: Phase 2/Phase 3
406
Phase: Phase 1/Phase 2
394
Medical Condition: Health Condition 1: C00-D49-...
212
Recruitment Status: Closed to Recruitment of Pa...
180
Medical Condition: -C50 Malignant neoplasm of b...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
26.540
2020-
14.978
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
40.916
Englisch
438
Unbestimmt
74
Spanisch
20
Deutsch
18
Französisch
14
Italienisch
12
Dänisch
10
Niederländisch
2
Finnisch
2
Isländisch
2
Latein
2
Manx
2
Nyanja
2
Portugiesisch
2
Schwedisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...